126 related articles for article (PubMed ID: 36780970)
1. CBX2-mediated suppression of SIAH2 triggers WNK1 accumulations to promote glycolysis in hepatocellular carcinoma.
Xu Z; Wu Y; Yang M; Wei H; Pu J
Exp Cell Res; 2023 May; 426(1):113513. PubMed ID: 36780970
[TBL] [Abstract][Full Text] [Related]
2. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma.
Ho YJ; Chang J; Yeh KT; Gong Z; Lin YM; Lu JW
In Vivo; 2020; 34(5):2631-2640. PubMed ID: 32871793
[TBL] [Abstract][Full Text] [Related]
4. Loss of WNK1 Suppressed the Malignant Behaviors of Hepatocellular Carcinoma Cells by Promoting Autophagy and Activating AMPK Pathway.
Wang F; Yan X; Shi G; Zhang L; Jing X
Dis Markers; 2022; 2022():6831224. PubMed ID: 36618969
[TBL] [Abstract][Full Text] [Related]
5. Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts.
Meng Q; Zhou Q; Chen X; Chen J
Aging (Albany NY); 2023 Nov; 15(22):12817-12851. PubMed ID: 37980163
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
Li J; Guo ZX; Chen JA; Xue C; Sun LL; Ren ZG; Li A; Cui GY; Yu ZJ
Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):192-197. PubMed ID: 30929335
[No Abstract] [Full Text] [Related]
7. The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1.
Ma Y; Zong H; Pan P; Shang H; Yang X
Exp Cell Res; 2024 May; 438(1):114006. PubMed ID: 38599542
[TBL] [Abstract][Full Text] [Related]
8. CENPL accelerates cell proliferation, cell cycle, apoptosis, and glycolysis via the MEK1/2-ERK1/2 pathway in hepatocellular carcinoma.
He K; Xie M; Hong W; Li Y; Yin Y; Gao X; He Y; Chen Y; You C; Li J
Int J Biochem Cell Biol; 2024 Jan; 166():106481. PubMed ID: 37914022
[TBL] [Abstract][Full Text] [Related]
9. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
Yang F; Lv LZ; Cai QC; Jiang Y
World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
[TBL] [Abstract][Full Text] [Related]
10. A functional loop between YTH domain family protein YTHDF3 mediated m
Zhou R; Ni W; Qin C; Zhou Y; Li Y; Huo J; Bian L; Zhou A; Li J
J Exp Clin Cancer Res; 2022 Dec; 41(1):334. PubMed ID: 36471428
[TBL] [Abstract][Full Text] [Related]
11. WNK1-OSR1 Signaling Regulates Angiogenesis-Mediated Metastasis towards Developing a Combinatorial Anti-Cancer Strategy.
Hou CY; Ma CY; Lin YJ; Huang CL; Wang HD; Yuh CH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292952
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
13. CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
Han Q; Li C; Cao Y; Bao J; Li K; Song R; Chen X; Li J; Wu X
Cancer Med; 2019 Jul; 8(8):3981-3991. PubMed ID: 31150156
[TBL] [Abstract][Full Text] [Related]
14. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
15. Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.
Tan HW; Leung CO; Chan KK; Ho DW; Leung MS; Wong CM; Ng IO; Lo RC
Int J Cancer; 2019 Oct; 145(7):1860-1873. PubMed ID: 30834518
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.
Lu C; Fang S; Weng Q; Lv X; Meng M; Zhu J; Zheng L; Hu Y; Gao Y; Wu X; Mao J; Tang B; Zhao Z; Huang L; Ji J
Cell Commun Signal; 2020 Jun; 18(1):97. PubMed ID: 32576292
[TBL] [Abstract][Full Text] [Related]
17. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
18. Identification of hepatocellular carcinoma subtypes based on PcG-related genes and biological relevance with cancer cells.
Fu Y; Yang K; Wu K; Wang H; Li Q; Zhang F; Yang K; Yao Q; Ma X; Deng Y; Zhang J; Liu C; Qu K
Clin Epigenetics; 2022 Dec; 14(1):184. PubMed ID: 36566204
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
20. CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression.
Huo W; Tan D; Chen Q
Nephron; 2020; 144(8):388-399. PubMed ID: 32570259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
